(Stroke. 1995;26:1086-1092.)
© 1995 American Heart Association, Inc.
Articles |
From the Department of Neurosurgery, The Mount Sinai School of Medicine, New York, NY.
Correspondence to Joshua B. Bederson, MD, Department of Neurosurgery, Box 1136, The Mount Sinai School of Medicine, 1 Gustave L. Levy Pl, New York, NY 10029.
| Abstract |
|---|
|
|
|---|
Methods CPP (mean arterial pressure minus intracranial pressure), cortical laser-Doppler flowmetry (LDF), and electroencephalogram were continuously recorded during and after SAH in 16 ventilated rats. SAH was produced by advancing an intraluminal suture from the external carotid artery through the internal carotid artery to perforate the vessel near its intracranial bifurcation.
Results Eight rats (50%) died within 24 hours of SAH. In all rats, blood was widely distributed throughout the basal, convexity, and interhemispheric subarachnoid spaces and throughout the ventricular system. CPP decreased after SAH at an initial rate of 1.1±0.2 mm Hg/s, reaching its nadir 59±9 seconds after the onset of SAH. During the same period, LDF fell at a rate of 1.4±0.3%/s (P=NS vs CPP). After reaching its nadir, CPP rose at a rate of 0.4±0.01 mm Hg/s, but LDF continued to fall at 0.2±0.03%/s (P<.05 vs CPP) reaching a nadir of 21.7±2.5% significantly later than CPP (189.5±39 s after SAH, P<.05). No correlation was found between peak changes in CPP and LDF. Electroencephalogram activity followed the changes in LDF, reaching nadir values 289±55 seconds after SAH.
Conclusions These findings demonstrate that although reduced CPP causes the initial decrease in cortical blood flow after SAH, secondary reductions occurring after CPP has reached its nadir are caused by other factors such as acute vasoconstriction. This noncraniotomy model of SAH in the rat has several advantages over existing models.
Key Words: animal models cerebral blood flow hemodynamics subarachnoid hemorrhage rats
| Introduction |
|---|
|
|
|---|
Currently available animal models of SAH6 8 9 10 11 12 13 14 15 16 17 are limited by the need for craniotomy and arachnoidal dissection or surgical placement of an infusion catheter, by the use of dorsal cisterns rather than the basal subarachnoid space, and by catheter-induced dampening of arterial pulsations, small elevations of ICP, or limited distribution of blood.
In this study we investigated a new rat model of SAH that avoids many problems of currently available models and allows continuous undisturbed measurements of cortical blood flow and CPP during the hemorrhage. Based on preliminary results,18 our primary hypothesis was that acute SAH-induced reductions in CBF are, at least in part, independent of reductions in CPP.
| Materials and Methods |
|---|
|
|
|---|
Rats were placed in a stereotaxic frame (Stoelting) modified to allow longitudinal rotation and permit manipulations with the rat prone or supine. Four 1-mm-diameter burr holes were placed 4 mm lateral, 2 mm rostral, and 2 mm caudal to bregma. Epidural electroencephalogram (EEG) electrodes were hooked under the edge of each burr hole and secured to the stereotaxic frame. Nasion reference and femoral ground electrodes were connected to a custom-built amplifier-computer (see below) to achieve a bilateral hemispheric bipolar EEG montage.
For measurement of cortical blood flow, a 3-mm burr hole was made 5 mm to the left of midline at the coronal suture, and a laser-Doppler flowmetry (LDF) probe (0.8 mm diameter, model P-433, Vasamedics Inc) was advanced under stereotaxic control to the cortical epidural surface away from large pial vessels. The side contralateral to the site of SAH was chosen to ensure that observed changes were attributable to SAH rather than to transient occlusion. A modification of the technique of Barth et al19 was used to monitor ICP. A burr hole was made in the midline occipital bone to accept a stainless steel screw. A 25-gauge butterfly cannula primed with saline and attached to a pressure transducer centered at the ear bars was advanced through the atlanto-occipital membrane into the cisterna magna until a good ICP waveform was obtained. The cannula was secured to the screw with methylmethacrylate cement. The rat was then rotated into the supine position with all recording devices in place and kept there for the remainder of the experiment.
Induction of SAH
The cerebral ischemia model of Zea-Longa et
al20 was modified to produce SAH. In brief, the right
carotid artery was identified along with all its extracranial branches,
and the external carotid artery was dissected, transected distally, and
reflected inferiorly. A 3-0 monofilament suture with one end sharpened
was advanced centripetally into the external carotid artery past the
common carotid bifurcation and into the internal carotid artery (ICA).
The suture was advanced distally into the intracranial ICA until
resistance was felt (at 18 to 20 mm) and then was pushed 3 mm further,
penetrating the ICA near its intracranial bifurcation (n=18).
Preliminary studies in 4 rats showed that the suture penetrated the
ICA, middle cerebral artery, or anterior cerebral artery within 1 mm of
the intracranial bifurcation. The suture was then withdrawn into the
external carotid artery, reperfusing the ICA and producing SAH (Fig 1
).18 The duration of endovascular
occlusion was 30 seconds to 4 minutes. Four sham-operated control rats
underwent an identical procedure except that the suture was not
advanced beyond the point of resistance; reperfusion occurred after 4
minutes of occlusion. After each experiment, the ICP catheter was
crimped and cut at its attachment to the occipital screw, which was
left in situ. Rats were returned to single, warmed cages while still
intubated for airway protection. Self-extubation occurred as the rats
recovered from anesthesia, usually within 30 minutes. Rats underwent
neurological examination after recovery from anesthesia and 24 hours
after SAH, as previously described,21 and were killed
after the second examination.
|
Data Acquisition and Storage
Blood pressure, LDF, ICP, and EEG waveforms were processed and
stored on a Macintosh Quadra 950 (Apple Computer Inc) by use of
customized analog-to-digital signal conversion and processing hardware
and software from National Instruments (SCSI, NB-MIO16XL,
LABVIEW 3.0). The system was configured to acquire 16
bipolar signals at sampling rates of 1024 Hz. The EEG signal was
processed on-line with a fast Fourier transform at 4-second intervals,
and the resulting spectrum was divided into power bands. LDF, ICP, mean
arterial pressure (MAP), and the amplitude (µV2) of the
delta power band (1 to 4 Hz) were logged at 0.25 Hz. CPP, defined as
MAP minus ICP, was computed for each pair of simultaneously logged data
points. LDF data were normalized by comparing each 4-second epoch to
the average of all values obtained during a 10-minute baseline before
SAH, and are expressed as a percent of baseline. After each experiment,
the data were converted to spreadsheet format for graphic analysis
(KALEIDEGRAPH, Synergy Software Inc) and statistical
analysis (STATVIEW 4.01, Abacus Concepts Inc).
Statistical Analysis
For comparing serial changes in different animals, the
x-axis (time) was set to zero at the onset of SAH, defined
as the initial positive deflection in ICP. For determining the
statistical significance of changes in CPP, LDF, and EEG, the values in
each rat 15 seconds before and 15 seconds after their maximum
deflections and at 25 and 50 minutes after SAH were averaged to avoid
potential sampling errors due to minor variations in the onset of SAH.
The rate of change was expressed as the slope of linear regression
derived from CPP or LDF versus time, and averages were compared by use
of Student's t test.22
Repeated-measures ANOVA was used for serial comparisons, and the Bonferroni correction for post hoc analysis was applied; P<.05 was considered significant. Minimum LDF and minimum CPP (mCPP) were determined for each rat as described above, and regression analysis was performed on pooled minimum LDF versus minimum CPP data. Data are expressed as mean±SEM.
Histological Examination
Brains were frozen at -22°C, and serial coronal sections 10
µm thick were cut in a cryostat at -20°C and mounted on subbed
slides. Sections were stained with Luxol blue (0.1%), counterstained
with buffered cresyl violet (2% in 100 mL of phosphate buffered
saline, pH 7.4), and exposed to diaminobenzidine. Other sections were
hydrated and stained with Wright's solution (1%).
| Results |
|---|
|
|
|---|
|
There were no significant differences in pH, PCO2, PO2, or body temperature before and 30 minutes after SAH (Table). Rats were initially lethargic after recovering from anesthesia, but no rat had a focal neurological deficit. Eight of 16 (50%) experimental rats died less than 24 hours after SAH, 2 within 2 hours, and 6 within 12 to 24 hours after SAH.
Physiological Data
CPP, LDF, ICP, and EEG tracings from an individual rat during
experimental SAH are shown in Fig 3
. Pooled data from
all 16 rats are shown in Fig 4
. CPP, LDF, and EEG
activity all decreased rapidly after the onset of SAH. Initially, the
changes in CPP and LDF were similar, but approximately 1 minute after
SAH, CPP began to rise from its nadir while LDF continued to fall. CPP
decreased from 96.3±0.5 mm Hg before SAH to 32.0±6.3 mm Hg after
SAH, reaching its nadir 59.1±9 seconds after the onset of SAH. The
average rate of change in CPP, expressed as the slope of CPP versus
time from the onset of SAH to mCPP, was -1.1±0.2 mm Hg/s. During
this same period, LDF decreased at an average rate of 1.4±0.3%/s to
44±4.9% of baseline. This rate of change was not significantly
different from that of CPP during the same period. After reaching its
nadir, CPP rose toward the baseline at an initial rate of 0.4±0.01
mm Hg/s. During the same period, LDF continued to fall at a rate of
0.2±0.3%/s. This was significantly different from both the initial
rate of change in LDF (P<.05) and the rate of change in CPP
during the same period (P<.05). LDF reached a nadir of
21.7±2.5% of baseline 189.5±39 seconds after SAH, significantly
after CPP reached its nadir (Fig 4
). Linear regression analysis
demonstrated no significant relationship between minimum LDF and
minimum CPP (y=17-0.01x,
r=.01; P=NS) (Fig 5
).
|
|
|
By 25 and 50 minutes after the onset of SAH, CPP was 75.5±6.1 and 71.7±5.3 mm Hg and LDF was 56.8±10.3% and 51.7±9.6% of baseline, respectively. For both measures, these values were significantly greater than the nadir values but less than baseline (P<.05). EEG delta activity fell to 51.2±24% of baseline after SAH (P<.05), reaching its nadir 289±55 seconds after SAH, significantly later than CPP or LDF. By 25 and 50 minutes after SAH, EEG delta activity was unchanged at 46.5±15% and 47.8±14% of baseline, respectively. Sham-operated rats had no changes in CPP, LDF, or EEG activity contralateral to the endovascular suture.
| Discussion |
|---|
|
|
|---|
A potential disadvantage of our model is the brief period of ischemia caused by the intraluminal suture. Endovascular middle cerebral artery occlusion produces infarction unless reperfusion occurs within 30 minutes.20 In this experiment, less than 4 minutes of transient middle cerebral artery occlusion was required, and as we have accumulated experience in subsequent studies this has been reduced to 30 to 60 seconds. This duration of focal ischemia is significantly shorter than that required to produce infarction.23 Control rats had no reductions in contralateral LDF or EEG and no evidence of ischemic histological change at 24 hours. Therefore, all changes observed in the experimental rats were due to the hemorrhage. Another disadvantage of the model is the incidence of intracerebral hemorrhage (11% in this series). Finally, 50% of rats died less than 24 hours after SAH. An analysis of the physiological predictors of mortality in this model, an investigation of histological changes 3 and 7 days after SAH, and histopathological studies of the intracranial vessels for evidence of delayed vasospasm are the subjects of a future report.
Measurement of CBF After SAH
Previous studies of CBF after SAH in humans and animals have used
time-averaged or discrete point-in-time determinations obtained by a
variety of techniques, including radiolabeled
microspheres,13 single photon emission computed
tomography,24 25 26 xenon computed
tomography,27 28 hydrogen clearance,29
autoradiography,30 or positron emission
tomography.31 These studies have shown that average CBF
measured shortly after SAH is 50% to 60% of baseline values. In
contrast, using LDF as a continuous measure of cortical perfusion, we
observed dynamic flow changes after SAH, with transient decreases to
22% of baseline. These brief decreases would be underestimated or
missed by time-averaged or single measurements of CBF. In addition,
comparison of LDF with CPP during the acute phases of SAH demonstrated
temporal and quantitative relationships between these two variables
that cannot be observed with other measures of CBF.
LDF has the disadvantage of being an unreliable indicator of absolute CBF.32 In addition, the ischemic thresholds for LDF have not been precisely defined for either global or focal cerebral ischemia.33 Nevertheless, LDF accurately reflects relative changes in CBF,32 and the magnitude of changes in CBF observed in our study are capable of producing cerebral infarction in other rat models of ischemia.23 34
Cerebral Ischemia After SAH
What are the likely explanations for the decreased cortical blood
flow immediately after SAH that was observed in our model? Decreased
CPP is one obvious factor: it occurred in all rats, was closely
associated with the onset of decreased LDF, and the rates of change in
CPP and LDF were similar while CPP was decreasing. However, LDF
continued to fall while CPP rose toward baseline and reached its nadir
more than 2 minutes after CPP did. In addition, no correlation was
found between peak reductions in CPP and LDF. Finally, CPP returned to
more than 70 mm Hg between 25 and 50 minutes after SAH, a level that
does not normally reduce CBF,35 while LDF remained
approximately 50% below baseline. Thus, factors other than CPP are
important contributors to acutely decreased cortical blood flow after
SAH. Two other potential mechanisms are primary SAH-induced
vasoconstriction and flow-metabolic coupling with a primary reduction
in metabolic activity. Metabolic activity, as reflected by the EEG,
decreased after SAH in all rats, but reached its nadir more than 1
minute after LDF. Therefore, it is unlikely that reduced EEG activity
was the main cause of secondary reductions in cortical blood flow in
this model.
Because LDF measurements depend on refraction of light, it is possible that direct interference with the laser signal by subarachnoid blood, rather than vasoconstriction or decreased CPP, could decrease LDF recordings in our model. We do not believe this played a significant role because slight pressure of the probe on the dura prevents the accumulation of subarachnoid blood under the probe, and LDF values decreased profoundly even in rats with little or no blood in the dorsal convexity subarachnoid space.
Vasoconstriction is the primary event underlying delayed cerebral ischemia after SAH, and a wide range of substrates have been implicated in its etiology. Hemoglobin and oxyhemoglobin cause vasoconstriction after SAH.36 Although various potential mechanisms have been identified,37 38 39 impairment of endothelium-dependent relaxation plays an important role in the process.37 Recent studies have focused on the potent vasodilator and endothelium-derived relaxing factor nitric oxide (NO) or an NO-related compound in the control of normal vasodilatory tone37 by a cyclic cGMPdependent mechanism.40 After SAH, hemoglobin and oxyhemoglobin can cause vasoconstriction by binding to NO and limiting its activity,34 by decreasing cGMP levels,41 or by generating cyclooxygenase products.42
Because of clinical interest in delayed cerebral vasospasm, many studies have emphasized the delayed effects of hemoglobin and NO synthase inhibitors. However, in animal models these substances have also been shown to cause early vasoconstriction.7 10 12 In fact, a direct vasoconstrictive action of subarachnoid blood has been suggested as the primary cause of ischemia after SAH.10 Our data indicate that both decreased CPP and direct vasoconstriction contribute to acute cerebral ischemia after SAH. During the first minute after the onset of SAH, reduced CPP predominates in reducing blood flow. Secondary reductions are caused by independent factors such as vasoconstriction.
The importance of secondary ischemia (ie, ischemia unrelated to perfusion pressure) in the acute phases after SAH is unknown. However, the acutely decreased CBF and persistent hypoperfusion for at least 1 hour after SAH in our experimental model suggest that secondary ischemia may contribute significantly to neurological mortality and morbidity. This observation lends further support to the use of agents that could alter acute vasoconstriction or neuronal ischemic damage immediately after SAH. For example, attenuation of acute ischemic neuronal injury may contribute to the beneficial effects of nimodipine43 44 and the 21-aminosteroids in SAH.45 46 Further studies are needed to address this issue.
Conclusion
A noncraniotomy model of SAH has several
advantages over models that require craniotomy, vessel
avulsion, or injection of blood. Real-time recordings of LDF provide
dynamic information about the causes of ischemia after SAH.
Decreased CPP cannot fully explain acute cerebral ischemia
after SAH, and there is evidence to support direct vasoconstriction as
one additional mechanism. Further studies of this model of SAH are
required to determine the physiological correlates of premature
mortality, the incidence and cause of ischemic histological
changes, the evidence for delayed vasospasm, and the effect on outcome
of treating acute vasoconstriction and ischemia.
| Acknowledgments |
|---|
Received September 19, 1994; revision received December 6, 1994; accepted February 27, 1995.
| References |
|---|
|
|
|---|
2. Stoltenburg-Didinger G, Schwarz K. Brain lesions secondary to subarachnoid hemorrhage due to ruptured aneurysms. In: Cervos-Navarro J, Ferst R, eds. Stroke and Microcirculation. New York, NY: Raven Press Publishers; 1987:471-480.
3. Fisher CM. Clinical syndromes in cerebral thrombosis, hypertensive hemorrhage, and ruptured saccular aneurysm. Clin Neurosurg. 1975;22:117-147. [Medline] [Order article via Infotrieve]
4. Nornes H. The role of intracranial pressure in the arrest of hemorrhage in patients with ruptured intracranial aneurysm. J Neurosurg. 1973;9:226-234.
5. Nornes H. Cerebral arterial flow dynamics during aneurysm haemorrhage. Acta Neurochir (Wien). 1978;41:39-48. [Medline] [Order article via Infotrieve]
6. Dorsch NW, Branston NM, Symon L. Intracranial pressure changes following primate subarachnoid hemorrhage. Neurol Res. 1989;11:201-204. [Medline] [Order article via Infotrieve]
7. Kuyama H, Ladds A, Branston NM, Nitta M, Symon L. An experimental study of acute subarachnoid haemorrhage in baboons: changes in cerebral blood volume, blood flow, electrical activity and water content. J Neurol Neurosurg Psychiatry. 1984;4:354-364.
8. McCormick PW, McCormick J, Zabramski JM, Spetzler RF. Hemodynamics of subarachnoid hemorrhage arrest. J Neurosurg. 1994;80:710-715. [Medline] [Order article via Infotrieve]
9.
Jakubowski J, Bell BA, Symon L, Zawirski MB, Francis
DM. A primate model of subarachnoid hemorrhage: change in
regional cerebral blood flow, autoregulation carbon dioxide reactivity,
and central conduction time. Stroke. 1982;13:601-611.
10. Jakowski A, Crockard A, Burnstack G, Russel R, Kristek F. The time course of intracranial pathophysiological changes following experimental subarachnoid hemorrhage in the rat. J Cereb Blood Flow Metab. 1990;10:835-839. [Medline] [Order article via Infotrieve]
11. Brawley B, Strandness D, Kelly W. The biphasic response of cerebral vasospasm in experimental subarachnoid hemorrhage. J Neurosurg. 1968;28:1-8. [Medline] [Order article via Infotrieve]
12.
Delgado TJ, Brismar J, Svendgaard NA.
Subarachnoid hemorrhage in the rat: angiography and fluorescence
microscopy of the major cerebral arteries. Stroke. 1985;16:595-602.
13. Diringer MN, Kirsch JR, Hanley DF, Traystman RJ. Altered cerebrovascular CO2 reactivity following subarachnoid hemorrhage in cats. J Neurosurg. 1993;8:915-921.
14. Hauerberg J, Juhler M, Rasmussen G. Cerebral blood flow autoregulation after experimental subarachnoid hemorrhage during hyperventilation in rats. J Neurosurg Anesthesiol. 1993;5:258-263. [Medline] [Order article via Infotrieve]
15.
Kader A, Krauss WE, Onesti ST, Elliott JP, Solomon RA.
Chronic cerebral blood flow changes following experimental
subarachnoid hemorrhage in rats. Stroke. 1990;21:577-581.
16. Lewis PJ, Weir BK, Nosko MG, Tanabe T, Grace MG. Intrathecal nimodipine therapy in a primate model of chronic cerebral vasospasm. Neurosurgery. 1988;22:492-500. [Medline] [Order article via Infotrieve]
17. Steiner L, Lofgren J, Zwetnow NN. Characteristics and limits of tolerance in repeated subarachnoid hemorrhage in dogs. Acta Neurol Scand. 1975;52:241-267. [Medline] [Order article via Infotrieve]
18. Bederson JB, Gaurino L, Germano IM. Failure of changes in cerebral perfusion pressure to account for ischemia caused by subarachnoid hemorrhage: a new experimental model. J Neurosci. 1994;20:224. Abstract.
19. Barth KN, Onesti ST, Krauss WE, Solomon RA. A simple and reliable technique to monitor intracranial pressure in the rat: technical note. Neurosurgery. 1992;30:138-140. [Medline] [Order article via Infotrieve]
20.
Zea-Longa E, Weinstein PR, Carlson S, Cummins R.
Reversible middle cerebral artery occlusion without craniectomy
in rats. Stroke. 1992;20:84-91.
21.
Bederson JB, Pitts LH, Tsuji M, Nishimura MC, Davis RL,
Bartkowski H. Rat middle cerebral artery occlusion: evaluation
of the model and development of a neurologic examination.
Stroke. 1986;17:472-476.
22. Zar JH. Biostatistical Analysis. Englewood Cliffs, NJ: Prentice Hall; 1984:292-305.
23.
Kaplan B, Brint S, Tanabe J, Jacewicz M, Wang X-J,
Pulsinelli W. Temporal thresholds for neocortical infarction in
rats subjected to reversible focal cerebral ischemia.
Stroke. 1991;22:1032-1039.
24. Heiss WD, Podreka I. Role of PET and SPECT in the assessment of ischemic cerebrovascular disease. Cerebrovasc Brain Metab Rev. 1993;5:235-263. [Medline] [Order article via Infotrieve]
25.
Lewis DH, Eskridge JM, Newell DW, Grady MS, Cohen WA,
Dalley RW, Loyd D, Grothaus-King A, Young P, Winn HR. Brain
SPECT and the effect of cerebral angioplasty in delayed
ischemia due to vasospasm. J Nucl Med. 1992;33:1789-1796.
26. Pupi A, De-Cristofaro MT, Passeri A, Castagnoli A, Santoro GM, Antoniucci D, Dal-Pozzo G, Pellicano G, Bacciottini L, Bottoncetti A. Quantitation of brain perfusion with 99mTc bicisate and single SPECT scan: comparison with microsphere measurements. J Cereb Blood Flow Metab. 1994;14:S28-S35.
27. Meixensberger J. Xenon 133CBF measurements in severe head injury and subarachnoid haemorrhage. Acta Neurochir Suppl (Wien). 1993;9:28-33.
28. Rasmussen G, Hauerberg J, Waldemar G, Gjerris F, Juhler M. Cerebral blood flow autoregulation in experimental subarachnoid haemorrhage in rat. Acta Neurochir (Wien). 1992;119:128-133. [Medline] [Order article via Infotrieve]
29. Nelson RJ, Perry S, Burns AC, Roberts J, Pickard JD. The effects of hyponatraemia and subarachnoid haemorrhage on the cerebral vasomotor responses of the rabbit. J Cereb Blood Flow Metab. 1991;11:661-666. [Medline] [Order article via Infotrieve]
30. Takeuchi H, Handa Y, Kobayashi H, Kawano H, Hayashi M. Impairment of cerebral autoregulation during the development of chronic cerebral vasospasm after subarachnoid hemorrhage in primates. Neurosurgery. 1991;28:41-48. [Medline] [Order article via Infotrieve]
31. Carpenter DA, Grubb RL Jr, Tempel LW, Powers WJ. Cerebral oxygen metabolism after aneurysmal subarachnoid hemorrhage. J Cereb Blood Flow Metab. 1991;11:837-844. [Medline] [Order article via Infotrieve]
32. Dirnagl U, Kaplan B, Jacewicz M, Pulsinelli W. Continuous measurement of cerebral cortical blood flow by laser-Doppler flowmetry in a rat stroke model. J Cereb Blood Flow Metab. 1989;9:589-596. [Medline] [Order article via Infotrieve]
33. Werner C. Laser Doppler flowmetry: a valid clinical tool? J Neurosurg Anesthesiol. 1993;5:139-141. [Medline] [Order article via Infotrieve]
34.
Nagasawa H, Kogure K. Correlation between
cerebral blood flow and histologic changes in a new rat model of middle
cerebral artery occlusion. Stroke. 1989;20:1037-1043.
35. Wagner EM, Traytsman R. Hydrostatic determinants of cerebral perfusion. Crit Care Med. 1986;114:484-490.
36.
Macdonald RL, Weir BK. A review of hemoglobin
and the pathogenesis of cerebral vasospasm. Stroke. 1991;22:971-982.
37. Faraci FM. Endothelium-derived vasoactive factors and regulation of the cerebral circulation. Neurosurgery. 1993;33:648-658. [Medline] [Order article via Infotrieve]
38. Fuwa I, Mayberg M, Gadjusek C, Harada T, Luo Z. Enhanced secretion of endothelin by endothelial cells in response to hemoglobin. Neurol Med Chir (Tokyo). 1993;33:739-743. [Medline] [Order article via Infotrieve]
39. Macrae IM, Robinson MJ, Graham DI, Reid JL, McCulloch J. Endothelin-linduced reductions in cerebral blood flow: dose dependency, time course, and neuropathological consequences. Cereb Blood Flow Metab. 1993;13:276-284. [Medline] [Order article via Infotrieve]
40. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1992;43:109-142. [Medline] [Order article via Infotrieve]
41. Edwards DH, Byrne JV, Griffith TM. The effect of chronic subarachnoid hemorrhage on basal endothelium-derived relaxing factor activity in intrathecal cerebral arteries. J Neurosurg. 1992;76:830-837. [Medline] [Order article via Infotrieve]
42.
Toda N, Ayajiki K, Okarriura T.
Endothelial modulation of contractions caused by oxyhemoglobin
and NG-nitro-L-arginine in
isolated dog and monkey cerebral arteries. Stroke. 1993;24:1584-1588.
43. Allen GS, Ahn HS, Preziosi TJ, Battye R, Boone SC, Chou SN, Kelly DL, Weir BK, Crabbe RA, Lavik PJ, Rosenbloom SB, Dorsey FC, Ingram CR, Mellits DE, Bertsch LA, Boisvert DP, Hundley MB, Johnson RK, Strom JA, Transou CR. Cerebral arterial spasm: a controlled trial of nimodipine in patients with subarachnoid hemorrhage. N Engl J Med. 1983;308:619-624. [Abstract]
44. Tettenborn D, Fierus M. Clinical aspects of nimodipine treatment in brain ischemia. Drugs Dev. 1993;2:473-482.
45. Kassell N, Haley EC, Alves W, Hansen CA. Phase III trial of tirilizad in aneurysmal subarachnoid hemorrhage. J Neurosci. 1994;80:383A. Abstract.
46. Hall ED, Travis MA. Effects of the nonglucocorticoid 21-aminosteroid U74006F on acute cerebral hypoperfusion following experimental subarachnoid hemorrhage. Exp Neurol. 1988;102:244-248. [Medline] [Order article via Infotrieve]
This article has been cited by other articles:
![]() |
J. B. Bederson, E. S. Connolly Jr, H. H. Batjer, R. G. Dacey, J. E. Dion, M. N. Diringer, J. E. Duldner Jr, R. E. Harbaugh, A. B. Patel, and R. H. Rosenwasser Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage: A Statement for Healthcare Professionals From a Special Writing Group of the Stroke Council, American Heart Association Stroke, March 1, 2009; 40(3): 994 - 1025. [Full Text] [PDF] |
||||
![]() |
J. Cahill and J. H. Zhang Subarachnoid Hemorrhage: Is It Time for a New Direction? Stroke, March 1, 2009; 40(3_suppl_1): S86 - S87. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Gallek, Y. P. Conley, P. R. Sherwood, M. B. Horowitz, A. Kassam, and S. A. Alexander APOE Genotype and Functional Outcome Following Aneurysmal Subarachnoid Hemorrhage Biol Res Nurs, January 1, 2009; 10(3): 205 - 212. [Abstract] [PDF] |
||||
![]() |
H. Endo, C. Nito, H. Kamada, F. Yu, and P. H. Chan Akt/GSK3{beta} Survival Signaling Is Involved in Acute Brain Injury After Subarachnoid Hemorrhage in Rats Stroke, August 1, 2006; 37(8): 2140 - 2146. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Cahill, J. W. Calvert, I. Solaroglu, and J. H. Zhang Vasospasm and p53-Induced Apoptosis in an Experimental Model of Subarachnoid Hemorrhage Stroke, July 1, 2006; 37(7): 1868 - 1874. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Park, M. Yamaguchi, C. Zhou, J.W. Calvert, J. Tang, and J. H. Zhang Neurovascular Protection Reduces Early Brain Injury After Subarachnoid Hemorrhage Stroke, October 1, 2004; 35(10): 2412 - 2417. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Yamaguchi, C. Zhou, A. Nanda, and J. H. Zhang Ras Protein Contributes to Cerebral Vasospasm in a Canine Double-Hemorrhage Model Stroke, July 1, 2004; 35(7): 1750 - 1755. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. F Lythgoe, N. R Sibson, and N. G Harris Neuroimaging of animal models of brain disease Br. Med. Bull., March 1, 2003; 65(1): 235 - 257. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Gules, M. Satoh, B. R. Clower, A. Nanda, and J. H. Zhang Comparison of three rat models of cerebral vasospasm Am J Physiol Heart Circ Physiol, December 1, 2002; 283(6): H2551 - H2559. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. McGirt, A. Parra, H. Sheng, Y. Higuchi, T. D. Oury, D. T. Laskowitz, R. D. Pearlstein, and D. S. Warner Attenuation of Cerebral Vasospasm After Subarachnoid Hemorrhage in Mice Overexpressing Extracellular Superoxide Dismutase Stroke, September 1, 2002; 33(9): 2317 - 2323. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. G. Matz, J.-C. Copin, P. H. Chan, and R. L. Macdonald Cell Death After Exposure to Subarachnoid Hemolysate Correlates Inversely With Expression of CuZn-Superoxide Dismutase Editorial Comment Stroke, October 1, 2000; 31(10): 2450 - 2459. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. A. Sehba, W. H. Ding, I. Chereshnev, J. B. Bederson, and J. P. Muizelaar Effects of S-Nitrosoglutathione on Acute Vasoconstriction and Glutamate Release After Subarachnoid Hemorrhage • Editorial Comment Stroke, September 1, 1999; 30(9): 1955 - 1961. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Busch, C. Beaulieu, A. de Crespigny, M. E. Moseley, and J. P. Muizelaar Diffusion MR Imaging During Acute Subarachnoid Hemorrhage in Rats • Editorial Comment Stroke, October 1, 1998; 29(10): 2155 - 2161. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Schmid-Elsaesser, S. Zausinger, E. Hungerhuber, A. Baethmann, H.-J. Reulen, and J. H. Garcia A Critical Reevaluation of the Intraluminal Thread Model of Focal Cerebral Ischemia : Evidence of Inadvertent Premature Reperfusion and Subarachnoid Hemorrhage in Rats by Laser-Doppler Flowmetry • Editorial Comment: Evidence of Inadvertent Premature Reperfusion and Subarachnoid Hemorrhage in Rats by Laser-Doppler Flowmetry Stroke, October 1, 1998; 29(10): 2162 - 2170. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Schmid-Elsaesser, S. Zausinger, E. Hungerhuber, N. Plesnila, A. Baethmann, and H.-J. Reulen Superior Neuroprotective Efficacy of a Novel Antioxidant (U-101033E) With Improved Blood-Brain Barrier Permeability in Focal Cerebral Ischemia Stroke, October 1, 1997; 28(10): 2018 - 2024. [Abstract] [Full Text] |
||||
![]() |
S. Ono, I. Date, M. Nakajima, K. Onoda, K. Ogihara, T. Shiota, S. Asari, Y. Ninomiya, N. Yabuno, T. Ohmoto, et al. Three-Dimensional Analysis of Vasospastic Major Cerebral Arteries in Rats With the Corrosion Cast Technique Stroke, August 1, 1997; 28(8): 1631 - 1638. [Abstract] [Full Text] |
||||
![]() |
F. Kehl, L. Cambj-Sapunar, K. G. Maier, N. Miyata, S. Kametani, H. Okamoto, A. G. Hudetz, M. L. Schulte, D. Zagorac, D. R. Harder, et al. 20-HETE contributes to the acute fall in cerebral blood flow after subarachnoid hemorrhage in the rat Am J Physiol Heart Circ Physiol, April 1, 2002; 282(4): H1556 - H1565. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1995 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |